Skip to main content

6 Result(s)

within Arimasa Shirasaki Remove this filter

and

  1. Article

    Open Access

    Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

    Previous studies reported conflicting results regarding an association between serum albumin concentration and the cumulative incidence of remission of proteinuria in adult patients with minimal change disease...

    Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama… in Scientific Reports (2022)

    Download PDF (1066 KB) View Article

  2. No Access

    Article

    Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

    Minimal change disease (MCD) is characterized by a nephrotic syndrome usually steroid-sensitive and a high incidence of relapse of proteinuria. Previous cohort studies have reported conflicting results regardi...

    Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama… in Journal of Nephrology (2022)

  3. No Access

    Article

    Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)

    The aim of the present study was to clarify the prevalence of immunosuppressive drug use and outcomes in elderly and non-elderly patients with primary membranous nephropathy (MN) in nationwide real-world pract...

    Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai… in Clinical and Experimental Nephrology (2020)

  4. Article

    Open Access

    Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)

    Despite recent advances in immunosuppressive therapy for patients with primary nephrotic syndrome, its effectiveness and safety have not been fully studied in recent nationwide real-world clinical data in Japan.

    Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama… in Clinical and Experimental Nephrology (2020)

    Download PDF (695 KB) View Article

  5. No Access

    Article

    Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study

    The lack of high-quality clinical evidences hindered broad consensus on optimal therapies for primary nephrotic syndromes. The aim of the present study was to compare prevalence of immunosuppressive drug use i...

    Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama… in Clinical and Experimental Nephrology (2018)

  6. Article

    Renovascular Hypertension: A Unique Cause of Unilateral Focal Segmental Glomerulosclerosis

    A 48-year-old man presented with malignant hypertension and massive proteinuria. Renal angiography showed complete obstruction of the left renal artery and 99mTc-mercaptoacetylglycine (MAG3) renography showed a n...

    Bassam Alchi, Arimasa Shirasaki, Ichiei Narita, Shinichi Nishi… in Hypertension Research (2006)

    Download PDF (921 KB)